When did FIBROGEN INC (FGEN) report earnings last quarter?
FIBROGEN INC (FGEN) last reported earnings on 11/10/2025.
FIBROGEN INC (FGEN) Earnings History & Surprises
NASDAQ:FGEN • US31572Q8814
Current stock price
9.71 USD
+0.69 (+7.65%)
At close:
9.75 USD
+0.04 (+0.41%)
After Hours:
FGEN Earnings overview
Past quarterly earnings results for FIBROGEN INC (FGEN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Mar 16, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$3.96
- Revenue Estimate
- 1.703M
Last Reported
Most Recent- Release Date
- Nov 10, 2025
- Period
- Q3 / 2025
- EPS Reported
- -$3.25
- EPS Surprise
- 20.44%
- Revenue Surprise
- -35.68%
Beat Rate
Last 8 Quarters 75%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -3.25 | -4.09 | 20.44% | 23.53% | 1.076M | 1.673M | -35.68% | -97.68% |
| Q2 2025 | -1.88 | -2.35 | 20.04% | 53.00% | 1.348M | 2.683M | -49.76% | -97.34% |
| Q1 2025 | 1.25 | 0.51 | 145.10% | 115.15% | 2.739M | 1.54M | 77.86% | -95.10% |
| Q4 2024 | 4.50 | -3.57 | 226.05% | 131.58% | 50.408M | 25.408M | 98.39% | 85.75% |
| Q3 2024 | -4.25 | -7.78 | 45.36% | 67.31% | 46.333M | 35.458M | 30.67% | 15.45% |
| Q2 2024 | -4.00 | -8.16 | 50.98% | 82.22% | 50.641M | 35.354M | 43.24% | 14.26% |
| Q1 2024 | -8.25 | -10.71 | 22.97% | 59.26% | 55.902M | 37.4M | 49.47% | 54.59% |
| Q4 2023 | -14.25 | -10.84 | -31.49% | 18.57% | 27.137M | 39.679M | -31.61% | -21.11% |
| Q3 2023 | -13.00 | -17.34 | 25.03% | 46.94% | 40.134M | 37.577M | 6.80% | 155.63% |
| Q2 2023 | -22.50 | -17.93 | -25.45% | -15.38% | 44.319M | 35.43M | 25.09% | 48.72% |
| Q1 2023 | -20.25 | -19.21 | -5.41% | -19.12% | 36.161M | 32.474M | 11.35% | -40.52% |
| Q4 2022 | -17.50 | -23.93 | 26.86% | 51.72% | 34.4M | 24.52M | 40.29% | 108.48% |
| Q3 2022 | -24.50 | -20.66 | -18.62% | -281.48% | 15.7M | 32.221M | -51.27% | -89.94% |
| Q2 2022 | -19.50 | -23.89 | 18.36% | 46.21% | 29.8M | 35.079M | -15.05% | 22.13% |
| Q1 2022 | -17.00 | -21.21 | 19.84% | 12.82% | 60.8M | 29.33M | 107.30% | 58.33% |
| Q4 2021 | -36.25 | -16.90 | -114.46% | -126.56% | 16.5M | 48.606M | -66.05% | -74.62% |
| Q3 2021 | 13.50 | -0.15 | 8,923.53% | 54.29% | 156M | 146.33M | 6.61% | 254.55% |
| Q2 2021 | -36.25 | -12.29 | -194.93% | -52.63% | 24.4M | 70.448M | -65.36% | -43.12% |
| Q1 2021 | -19.50 | -22.11 | 11.80% | 12.36% | 38.4M | 42.623M | -9.91% | 57.38% |
| Q4 2020 | -16.00 | -6.01 | -166.17% | - | 65M | 102.83M | -36.79% | - |
| Q3 2020 | 8.75 | -20.40 | 142.89% | - | 44M | 65.461M | -32.78% | - |
| Q2 2020 | -23.75 | -16.33 | -45.48% | - | 42.9M | 34.476M | 24.43% | - |
| Q1 2020 | -22.25 | -9.91 | -124.59% | - | 24.4M | 74.031M | -67.04% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
102.91%
Max EPS beat (4)
226.05%
Min EPS beat (4)
20.04%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
22.70%
Max Revenue beat (4)
98.39%
Min Revenue beat (4)
-49.76%
Analysis
In the last 4 quarters, FGEN has consistently beaten EPS estimates in all releases
FGEN has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, FGEN has beaten the EPS estimates by 102.9% on average.
In the last 4 quarters, FGEN has beaten the revenue estimates by 22.7% on average.
Related analysis
FIBROGEN INC / FGEN Earnings FAQ
Did FIBROGEN INC (FGEN) beat earnings estimates last quarter?
FIBROGEN INC (FGEN) beat EPS estimates and missed revenue estimates in the most recent quarter.
How often does FIBROGEN INC (FGEN) beat earnings estimates?
In the last 4 quarters, FIBROGEN INC (FGEN) has beaten EPS estimates in 4 out of 4 releases.